• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童胃肠道传输的特定方面用于药物输送设计。

Specific aspects of gastro-intestinal transit in children for drug delivery design.

机构信息

Department of Pharmaceutics, The School of Pharmacy, University of London, United Kingdom.

出版信息

Int J Pharm. 2010 Aug 16;395(1-2):37-43. doi: 10.1016/j.ijpharm.2010.04.048. Epub 2010 May 15.

DOI:10.1016/j.ijpharm.2010.04.048
PMID:20478372
Abstract

This mini-review discusses relevant aspects of gastro-intestinal transit in different ages of paediatric patients with an attempt to highlight factors which should be considered in oral dosage form design, in particular multi-particulate dosage forms. This emphasis is due to multi-particulates possessing many of the benefits of liquid oral formulations (such as ease of swallowing and dose adaptability) without many of their drawbacks (such as stability issues and lack of enteric or modified release functionalities). It is commonly stated that children are not merely small adults with regards to medicines. However, there has been very little research regarding how different dosage forms transit through the gastro-intestinal tract in children compared to adults, due to both ethical and practical hurdles. Due to this lack of studies on dosage form transit in children, information which was available on the transit of food, milk and liquids (often dependent upon the age of the patient) has been used to look at how various aspects of transit vary with age and, where possible, when they reach adult values and how these may affect the fate of dosage forms in vivo: swallowability, oesophageal transit, gastric emptying and pH, intestinal and colonic transit are discussed.

摘要

这篇小型综述讨论了不同年龄段儿科患者胃肠道转运的相关方面,试图强调在口服剂型设计中应考虑的因素,特别是多颗粒剂型。之所以强调这一点,是因为多颗粒剂型具有许多液体口服制剂的优点(如易于吞咽和剂量适应性),而没有许多缺点(如稳定性问题和缺乏肠溶或改良释放功能)。人们常说,儿童在药物方面不仅仅是小大人。然而,由于伦理和实际障碍,关于不同剂型在儿童和成人中的胃肠道转运情况的研究很少。由于对儿童剂型转运的研究不足,因此使用了有关食物、牛奶和液体转运的信息(通常取决于患者的年龄)来研究各种转运方面如何随年龄变化,以及在何时达到成人值,以及这些如何影响体内剂型的命运:可吞咽性、食管转运、胃排空和 pH 值、肠道和结肠转运。

相似文献

1
Specific aspects of gastro-intestinal transit in children for drug delivery design.儿童胃肠道传输的特定方面用于药物输送设计。
Int J Pharm. 2010 Aug 16;395(1-2):37-43. doi: 10.1016/j.ijpharm.2010.04.048. Epub 2010 May 15.
2
Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon.胃肠道内的靶向药物传递系统:从口腔到结肠。
Int J Pharm. 2010 Aug 16;395(1-2):44-52. doi: 10.1016/j.ijpharm.2010.05.003. Epub 2010 May 28.
3
Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption.口服缓控释制剂的运动:胃肠道转运与药物吸收的关系。
Int J Pharm. 2010 Aug 16;395(1-2):26-36. doi: 10.1016/j.ijpharm.2010.04.046. Epub 2010 May 28.
4
Gastroretentive dosage forms.胃滞留剂型
Crit Rev Ther Drug Carrier Syst. 1993;10(2):143-95.
5
The transit of dosage forms through the small intestine.剂型在小肠中的转运。
Int J Pharm. 2010 Aug 16;395(1-2):9-16. doi: 10.1016/j.ijpharm.2010.04.045. Epub 2010 May 15.
6
[Comparative evaluation of the gastric transit of floating and non-floating matrix dosage forms].[漂浮型和非漂浮型骨架剂型胃内转运的比较评价]
Bull Mem Acad R Med Belg. 1990;145(8-9):365-75.
7
Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis.药物完整输送至结肠的持续释放:美沙拉嗪制剂与胃肠道转运时间分析
Pharm Dev Technol. 2009;14(1):116-25. doi: 10.1080/10837450802420559.
8
Pharmaceutical approaches to colon targeted drug delivery systems.结肠靶向给药系统的药物学方法。
J Pharm Pharm Sci. 2003 Jan-Apr;6(1):33-66.
9
Formulation of medicines for children.儿童用药制剂
Br J Clin Pharmacol. 2005 Jun;59(6):674-6. doi: 10.1111/j.1365-2125.2005.02410.x.
10
Changes in availability of paediatric medicines in Australia between 1998 and 2002.1998年至2002年间澳大利亚儿科药品供应情况的变化。
Br J Clin Pharmacol. 2005 Jun;59(6):736-42. doi: 10.1111/j.1365-2125.2004.02211.x.

引用本文的文献

1
If a Child Vomits After an Oral Medication-Should We Re-Dose or Not?如果儿童口服药物后呕吐,我们是否应该重新给药?
Acta Paediatr. 2025 Oct;114(10):2506-2510. doi: 10.1111/apa.70121. Epub 2025 May 15.
2
Taste-Masked Flucloxacillin Powder Part 2: Formulation Optimisation Using the Mixture Design Approach and Storage Stability.掩味氟氯西林粉末 第2部分:采用混合设计方法的制剂优化及储存稳定性
Pharmaceuticals (Basel). 2023 Aug 18;16(8):1179. doi: 10.3390/ph16081179.
3
Nurses' knowledge and practice regarding mixing medications with food: a multicenter cross-sectional study from a developing country.
护士关于将药物与食物混合的知识和实践:来自发展中国家的一项多中心横断面研究。
J Health Popul Nutr. 2023 Jun 5;42(1):52. doi: 10.1186/s41043-023-00396-0.
4
A Survey from a Tertiary Care Hospital in India on Pediatric Medication Re-Dosing Practices After Patient Vomiting.印度一家三级医疗医院关于患儿呕吐后儿科用药重新给药做法的调查。
J Pediatr Pharmacol Ther. 2022;27(5):457-462. doi: 10.5863/1551-6776-27.5.457. Epub 2022 Jul 6.
5
Evaluating the Taste Masking Ability of Two Novel Dispersible Tablet Platforms Containing Zinc Sulfate and Paracetamol Reconstituted in a Breast Milk Substitute.评估两种新型分散片剂平台在母乳替代品中重构的含硫酸锌和对乙酰氨基酚制剂的掩味能力。
Pharmaceutics. 2022 Feb 15;14(2):420. doi: 10.3390/pharmaceutics14020420.
6
Development of a Pediatric Relative Bioavailability/Bioequivalence Database and Identification of Putative Risk Factors Associated With Evaluation of Pediatric Oral Products.建立儿科相对生物利用度/生物等效性数据库并确定与儿科口服制剂评估相关的潜在风险因素。
AAPS J. 2021 Apr 21;23(3):57. doi: 10.1208/s12248-021-00592-y.
7
Guidance on the risk assessment of substances present in food intended for infants below 16 weeks of age.16周龄以下婴儿食用食品中所含物质的风险评估指南。
EFSA J. 2017 May 31;15(5):e04849. doi: 10.2903/j.efsa.2017.4849. eCollection 2017 May.
8
Protein Digestion and Quality of Goat and Cow Milk Infant Formula and Human Milk Under Simulated Infant Conditions.模拟婴儿条件下山羊奶和牛奶婴儿配方奶粉及母乳中的蛋白质消化与质量
J Pediatr Gastroenterol Nutr. 2017 Dec;65(6):661-666. doi: 10.1097/MPG.0000000000001740.
9
Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions.儿科口服药物吸收:肠壁、其发育变化及当前的预测工具
Biopharm Drug Dispos. 2017 Apr;38(3):209-230. doi: 10.1002/bdd.2052. Epub 2017 Feb 6.
10
In vitro assessment of iron availability from commercial Young Child Formulae supplemented with prebiotics.商业婴幼儿配方食品添加益生元后铁的体外可利用率评估。
Eur J Nutr. 2018 Mar;57(2):669-678. doi: 10.1007/s00394-016-1353-3. Epub 2016 Dec 9.